Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.90
+0.25 (2.59%)
Aug 14, 2025, 11:39 AM - Market open
Elicio Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 22.09 | 17.62 | 12.89 | 6.16 | 9.28 | 14.97 | Upgrade
|
| Cash & Short-Term Investments | 22.09 | 17.62 | 12.89 | 6.16 | 9.28 | 14.97 | Upgrade
|
| Cash Growth | 544.90% | 36.64% | 109.45% | -33.66% | -38.01% | 119.78% | Upgrade
|
| Prepaid Expenses | 0.3 | 1.65 | 2.43 | 2.27 | 0.18 | 0.17 | Upgrade
|
| Restricted Cash | - | 1.18 | 0.72 | 1.64 | 0.15 | 0.15 | Upgrade
|
| Other Current Assets | 0.21 | 0.24 | 0.3 | 0.65 | 0.76 | 0.17 | Upgrade
|
| Total Current Assets | 22.6 | 20.69 | 16.35 | 10.72 | 10.36 | 15.45 | Upgrade
|
| Property, Plant & Equipment | 5.63 | 6.19 | 7.28 | 8.5 | 0.89 | 1.02 | Upgrade
|
| Other Long-Term Assets | 1.3 | 1.3 | 3.52 | 3.45 | 3.57 | 3.18 | Upgrade
|
| Total Assets | 29.53 | 28.18 | 27.15 | 22.66 | 14.81 | 19.66 | Upgrade
|
| Accounts Payable | 3.87 | 1.04 | 4.37 | 2.81 | 1.68 | 1.65 | Upgrade
|
| Accrued Expenses | 5.11 | 8.42 | 3.76 | 1.94 | 2.32 | 1.22 | Upgrade
|
| Short-Term Debt | - | - | - | - | 11.8 | - | Upgrade
|
| Current Portion of Leases | 0.95 | 0.9 | 0.91 | 0.69 | - | 0.44 | Upgrade
|
| Other Current Liabilities | - | 1.17 | 0.72 | 1.44 | 3.09 | - | Upgrade
|
| Total Current Liabilities | 9.92 | 11.52 | 9.76 | 6.87 | 18.88 | 3.31 | Upgrade
|
| Long-Term Debt | 9.34 | 20.03 | - | - | - | - | Upgrade
|
| Long-Term Leases | 4.61 | 5.11 | 6.01 | 6.79 | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.82 | 2.83 | 0.01 | 0.09 | 0.03 | - | Upgrade
|
| Total Liabilities | 27.69 | 39.49 | 15.77 | 13.75 | 18.91 | 3.31 | Upgrade
|
| Common Stock | 0.16 | 0.11 | 0.1 | 0 | 0.17 | 0.13 | Upgrade
|
| Additional Paid-In Capital | 217.76 | 183 | 153.83 | 4.86 | 4.09 | 3.34 | Upgrade
|
| Retained Earnings | -215.87 | -194.1 | -142.2 | -107.01 | -78.8 | -52.4 | Upgrade
|
| Treasury Stock | -0.15 | -0.15 | -0.15 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -0.07 | -0.18 | -0.2 | - | - | -0.21 | Upgrade
|
| Total Common Equity | 1.83 | -11.31 | 11.37 | -102.15 | -74.54 | -49.14 | Upgrade
|
| Shareholders' Equity | 1.83 | -11.31 | 11.37 | 8.92 | -4.1 | 16.35 | Upgrade
|
| Total Liabilities & Equity | 29.53 | 28.18 | 27.15 | 22.66 | 14.81 | 19.66 | Upgrade
|
| Total Debt | 14.9 | 26.04 | 6.92 | 7.48 | 11.8 | 0.44 | Upgrade
|
| Net Cash (Debt) | 7.19 | -8.42 | 5.98 | -1.33 | -2.52 | 14.53 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | 144.47% | Upgrade
|
| Net Cash Per Share | 0.51 | -0.69 | 1.18 | -4.19 | -0.16 | 1.35 | Upgrade
|
| Filing Date Shares Outstanding | 16.32 | 15.94 | 10.22 | 17.7 | 17.14 | 13.06 | Upgrade
|
| Total Common Shares Outstanding | 16.26 | 11.03 | 9.6 | 17.7 | 17.14 | 13.06 | Upgrade
|
| Working Capital | 12.68 | 9.17 | 6.59 | 3.85 | -8.52 | 12.15 | Upgrade
|
| Book Value Per Share | 0.11 | -1.03 | 1.18 | -5.77 | -4.35 | -3.76 | Upgrade
|
| Tangible Book Value | 1.83 | -11.31 | 11.37 | -102.15 | -74.54 | -49.14 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | -1.03 | 1.18 | -5.77 | -4.35 | -3.76 | Upgrade
|
| Machinery | 1.9 | 1.9 | 1.82 | 2.15 | - | 1.12 | Upgrade
|
| Leasehold Improvements | 0.13 | 0.13 | 0.13 | 0.12 | - | - | Upgrade
|
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.